Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41380-022-01615-6
PubMed Identifier: 35618884
Publication URI: http://europepmc.org/abstract/MED/35618884
Type: Journal Article/Review
Volume: 27
Parent Publication: Molecular psychiatry
Issue: 9
ISSN: 1359-4184